Korro Bio (KRRO) Assets (2018 - 2026)
Korro Bio's (KRRO) quarterly Assets came in at $183.6 million in Q1 2026, down 9.19% YoY from $202.2 million in Q1 2025, and up 61.77% on a QoQ basis from $113.5 million in Q4 2025.
Korro Bio (KRRO) Assets (2018 - 2026) Analysis & Trends
Korro Bio (KRRO) has 9 years of Assets data on file, last reported at $183.6 million in Q1 2026.
- Quarterly Assets fell 9.19% year-over-year to $183.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $183.6 million (down 9.19% YoY) and the FY2025 annual result came in at $113.5 million, down 49.83% from the prior year.
- Assets climbed to $183.6 million in Q1 2026, from $113.5 million in the prior quarter.
- In the past five years, Assets ranged from a high of $249.6 million in Q2 2024 to a low of $46.3 million in Q3 2023.
- A 5-year average of $160.7 million and a median of $164.9 million in 2022 frame the typical range for Assets.
- Annual changes were most pronounced in 2023 — Assets sank 65.92% — and 2024, when it soared 425.45%.
- Tracing KRRO's Assets over 5 years: stood at $73.7 million in 2022, then soared by 200.59% to $221.7 million in 2023, then advanced by 2.06% to $226.2 million in 2024, then plunged by 49.83% to $113.5 million in 2025, then soared by 61.77% to $183.6 million in 2026.
- The last three Assets figures came in at $183.6 million (Q1 2026), $113.5 million (Q4 2025), and $161.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Korro Bio | 228.60 Mn | 113.56 Mn | - | 163.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 163.45 Mn |
| Mar 31, 2026 | 183.62 Mn |
| Dec 31, 2025 | 113.51 Mn |
| Sep 30, 2025 | 161.55 Mn |
| Jun 30, 2025 | 180.43 Mn |
| Mar 31, 2025 | 202.21 Mn |
| Dec 31, 2024 | 226.24 Mn |
| Sep 30, 2024 | 243.54 Mn |
| Jun 30, 2024 | 249.59 Mn |
| Mar 31, 2024 | 197.99 Mn |
| Dec 31, 2023 | 221.66 Mn |
| Sep 30, 2023 | 46.35 Mn |
| Jun 30, 2023 | 79.38 Mn |
| Mar 31, 2023 | 101.50 Mn |
| Dec 31, 2022 | 73.74 Mn |
| Sep 30, 2022 | 136.01 Mn |
| Jun 30, 2022 | 149.66 Mn |
| Mar 31, 2022 | 164.94 Mn |
| Dec 31, 2021 | 185.36 Mn |
| Sep 30, 2021 | 202.19 Mn |